Properties (66)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
medical device
|
| gptkbp:approves |
gptkb:FDA
|
| gptkbp:availability |
available in select markets
|
| gptkbp:careInstructions |
standard surgical risks apply
|
| gptkbp:clinicalTrials |
Phase 3
ongoing studies improved vision demonstrated efficacy in trials recommended for specific cases data supports its use guidance provided to clinicians implanted during surgery improved patient outcomes reported included in glaucoma treatment guidelines multiple trials conducted protocols established for use. significant clinical impact expected specific criteria for patients surgeon experience impacts outcomes |
| gptkbp:collaborations |
collaborated with ophthalmologists
|
| gptkbp:community |
impact on healthcare delivery
|
| gptkbp:community_service |
ab-externo approach
considered a surgical innovation minimally invasive technique positive surgical outcomes reported |
| gptkbp:communityOutreach |
outreach programs initiated
|
| gptkbp:competesWith |
other glaucoma treatments
|
| gptkbp:complications |
low rate of complications
|
| gptkbp:contraindication |
minimal complications
|
| gptkbp:customerFeedback |
positive reviews
|
| gptkbp:designedFor |
reduce intraocular pressure
|
| gptkbp:developedBy |
gptkb:InnFocus,_Inc.
|
| gptkbp:finalDisposal |
requires regular follow-up visits
|
| gptkbp:firstIntroduced |
2018
|
| gptkbp:follows |
6 months
|
| gptkbp:future_plans |
future developments anticipated
|
| gptkbp:hasResearchInterest |
under evaluation
market research conducted |
| gptkbp:healthcare |
high satisfaction rates
careful patient selection recommended requires monitoring post-surgery requires patient education specific criteria apply supported by patient advocacy groups |
| https://www.w3.org/2000/01/rdf-schema#label |
InnFocus MicroShunt
|
| gptkbp:innovation |
represents innovation in glaucoma surgery
|
| gptkbp:insuranceAccepted |
may be covered by insurance
|
| gptkbp:manufacturer |
gptkb:InnFocus,_Inc.
|
| gptkbp:market |
launched in 2018
|
| gptkbp:marketedAs |
InnFocus_brand
|
| gptkbp:material |
biocompatible materials
|
| gptkbp:offers |
varies by region
|
| gptkbp:patentStatus |
patented technology
|
| gptkbp:postRetirementCareer |
approximately 30 minutes
requires follow-up visits |
| gptkbp:regulatoryCompliance |
CE mark obtained
|
| gptkbp:research |
supported by grants
|
| gptkbp:researchFocus |
ongoing research into effectiveness
|
| gptkbp:researchInterest |
published studies available
|
| gptkbp:safetyFeatures |
generally well-tolerated
|
| gptkbp:targets |
patients with open-angle glaucoma
|
| gptkbp:training |
surgeon training necessary
surgeons must undergo training |
| gptkbp:triggerType |
drains aqueous humor
|
| gptkbp:type |
minimally invasive surgical device
|
| gptkbp:usedFor |
treatment of glaucoma
|